The historical rank and industry rank for Sequana Medical NV's Net Margin % or its related term are showing as below:
STU:2SE'
s Net Margin % Range Over the Past 10 Years
Min: -6365.23 Med: -1450.66 Max: -630.75
Current: -3844.66
STU:2SE's Net Margin % is ranked worse than 96.11% of 822
companies
in the Medical Devices & Instruments industry
Industry Median: -1.34
vs STU:2SE: -3844.66
Sequana Medical NV Net Margin % Historical Data
The historical data trend for Sequana Medical NV's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sequana Medical NV's Net Margin %
For the Medical Devices subindustry, Sequana Medical NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV's Net Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's Net Margin % falls into.
Sequana Medical NV Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Sequana Medical NV's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sequana Medical NV (STU:2SE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sequana Medical NV Net Margin % Related Terms
Thank you for viewing the detailed overview of Sequana Medical NV's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:2SE has been successfully added to your 